Skip to content

Advertisement

  • Meeting abstract
  • Open Access

P01-044 – Uncommon manifestations of familial Mediterranean

  • 1,
  • 2 and
  • 2
Pediatric Rheumatology201311 (Suppl 1) :A47

https://doi.org/10.1186/1546-0096-11-S1-A47

  • Published:

Keywords

  • Systemic Lupus Erythematosus
  • Amyloidosis
  • Familial Mediterranean Fever
  • Spondyloarthropathy
  • Panniculitis

Introduction

Familial Mediterranean Fever (FMF) is the most common autoinflammatory disease characterized by recurrent self-limited attacks of fever accompanying with peritonitis, pleuritis or arthritis. The testing of MEFV gene expanded the frame of various clinical manifestations of FMF.

Objectives

The aim of this study is to determine systemic uncommon non-classical manifestations of FMF and reveal the possible association with autoimmune diseases.

Methods

We examined 50 patients (27 male, 23 female) with FMF. The mean age of patients was 34.7±12.2. FMF was determined clinically and approved by testing of MEFV gene. To reveal systemic manifestations of FMF investigation of all organ-systems was carried out.

Results

Classical symptoms of FMF: abdominalgy, thoracalgy, arthralgy with recurrent fever and pleuritis, splenomegaly, hepatomegaly were seen in almost all patients. Monoarthritis was met in 36 (72%) and polyarthritis in 8(16%) patients. 40(80%) patients developed spondyloarthrtitis, in 11 cases (22%) unilateral sacroiliitis and in 29(58%) bilateral sacroiliitis was observed. All patients with sacroiliitis fulfilled the classification criteria of the European Spondyloarthropathy Study Group for the diagnosis of seronegative spondyloarthropathy. 10(25%) patients of 40 that having sacroiliitis developed significant limitation of lumbar motion, which was assessed by Schober’s test (1-2 cm), had bilateral sacroiliits grade III-IV and fulfilled the modified New York criteria for ankylosing spondylitis. HLA B-27 was examined in 15 patients with symptoms of spondyloarthropathy. In 7 patients it was negative and in 8-positive. In19 (38%) from 50 patients coxarthrosis was revealed and 2 patients underwent total endoprothesis of hips. Skin involvement also was observed during the observation: 4(8%) of them developed erythema similar “butterfly” rash, livedo reticularis and photosensitivity with high titer of circulating immune complexes, ANA and anti-dsDNA antibodies like systemic lupus erythematosus, 1 patient had hemorrhagic rash on legs with developing of hemorrhagic vasculitis. In 1 patient trophic ulcers, miscarriage were developed with high titer of anticardiolopin autoantibodies as in classic antiphospholipid syndrome. Scleroderma-like syndrome was developed in 1 patient with Raynaud’s phenomenon and skin induration of wrists and face and pneumofibrosis. Also panniculitis (1 patient), aphthae (2 patients), angiorethinopathy(2 patients), mononeyropathy and polyneyropathy ( 2 patients respectively), pneumonitis (4 patients), xerophthalmia (1 patient) like Sjogren’s syndrome were observed. The prevalent mutation of MEFV gene was M694V- in 38patients (79.1%), from which 8(16.7%) were homozygote and 14(29%) were heterozygote (M694V/N).

Conclusion

FMF may have systemic manifestations of autoimmune diseases. It may be due to vascular involvement especially in accompaning amyloidosis cases. The peculiarity of ankylosing spondylitis-like syndrome in FMF is its independent existence from carrying HLA B-27 antigen.

Disclosure of interest

None declared.

Authors’ Affiliations

(1)
Rheumatology, Center of family planning and sexual health, Yerevan, Armenia
(2)
Internal Diseases, Yerevan State Medical University, Yerevan, Armenia

Copyright

Advertisement